SEARCH

SEARCH BY CITATION

References

  • Austyn, J. M., Hankins, D. F., Larsen, C. P., Morris, P. J., Rao, A. S. and Roake, J. A., Isolation and characterization of dendritic cells from mouse heart and kidney. J. Immunol., 152, 24012410 (1994).
  • Buelens, C., Willems, F., Delvaux, A., Piérard, G., Delville, J.-P., Velu, T. and Goldman, M., Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Europ. J. Immunol., 25, 26682672 (1995).
  • Caux, C., Dezutter-Dambuyant, C., Schmitt, D. and Banchereau, J., GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature (Lond.), 360, 258261 (1992).
  • Caux, C., Vanbervliet, B., Massacrier, C., Azuma, M., Okumura, M., Lanier, L. L. and Banchereau, J., B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. exp. Med., 180, 18411847 (1994).
  • Finke, J. H., Zea, A. H., Stanley, J., Longo, D. L., Mizoguchi, H., Tubbs, R. R., Wiltrout, R. H., O'Shea, J. J., Kudoh, S., Klein, E., Bukowski, R. M. and Ochoa, A. C., Loss of T-cell receptor zeta chain and p56Ick in T-cells infiltrating human renal cell carcinoma. Cancer Res., 53, 56135616 (1993).
  • Guinan, E. C., Gribben, J. G., Boussiotis, V. A., Freeman, G. J. and Nadler, L. M., Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood, 84, 32613282 (1994).
  • Heufler, C., Topar, G., Koch, F., Trockenbacher, B., Kämpgen, E., Romani, N. and Schuler, G., Cytokine gene expression in murine epidermal cell suspensions: interleukin-1α and macrophage inflammatory protein 1α are selectively expressed in Langerhans cells but are differentially regulated in culture. J. exp. Med., 176, 12211226 (1992).
  • Inaba, K., Inaba, M., Deguchi, M., Hagi, K., Yasumizu, R., Ikehara, S., Muramatsu, S. and Steinman, R. M., Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class-II-negative progenitor in mouse bone marrow. Proc. nat. Acad. Sci. (Wash.), 90, 30383042 (1993).
  • Inaba, K., Witmer-Pack, M., Inaba, M., Hathcock, K. S., Sakuta, H., Azuma, M., Yagita, H., Okumura, K., Linsley, P. S., Ikehara, S., Muramatsu, S., Hodes, R. J. and Steinman, R. M., The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. exp. Med., 180, 18491860 (1994).
  • Janeway, C. A., Jr., and Bottomly, K., Signals and signs for lymphocyte responses. Cell, 76, 275285 (1994).
  • Klein, E. A., Bukowski, R. M. and Finke, J. H., Renal cell carcinoma: immunotherapy and cellular biology. Marcel Dekker, New York (1993).
  • Lenz, A., Heine, M., Schuler, G. and Romani, N., Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J. clin. Invest., 92, 25872596 (1993).
  • Lu, L., Woo, J., Rao, A. S., Li, Y., Watkins, S. C., Qian, S., Starzl, T. E., Demetris, A. J. and Thomson, A. W., Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J. exp. Med., 179, 18231834 (1994).
  • Ludewig, B., Graf, D., Gelderblom, H. R., Becker, Y., Kroczek, R. A. and Pauli, G., Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-a, but strongly enhanced by interleukin-10. Europ. J. Immunol., 25, 19431950 (1995).
  • Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J. Ildstad, S. T., Kast, W. M., Deleo, A. B. and Lotze, M. T., Bone-marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med., 1, 12971302 (1995).
  • McWilliam, A. S., Nelson, D., Thomas, J. A. and Holt, P. G., Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J. exp. Med., 179, 13311336 (1994).
  • Mitra, R. S., Judge, T. A., Nestle, F. O., Turka, L. A. and Nickoloff, B. J., Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J. Immunol., 154, 26682677 (1995).
  • Nakagomi, H., Pisa, P., Pisa, E. K., Yamamoto, Y., Halapi, E., Backlin, K., Juhlin, C. and Kiessling, R., Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal-cell carcinoma. Int. J. Cancer, 63, 366371 (1995).
  • Pope, M., Betjes, M. G. H., Hirmand, H., Hoffman, L. and Steinman, R. M., Both dendritic cells and memory T lymphocytes emigrate from organ cultures of human skin and form distinctive dendritic-T-cell conjugates. J. invest. Dermatol., 104, 1117 (1995).
  • Roake, J., Rao, A. S., Morris, P. J., Larsen, C. P., Hankins, D. F. and Austyn, J. M., Dendritic cell loss from nonlymphoid tissue after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin-1. J. exp. Med., 181, 22372247 (1995).
  • Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M. and Schuler, G., Proliferating dendritic cell progenitors in human blood. J. exp. Med., 180, 8393 (1994).
  • Sallusto, F., Cella, M., Danieli, C. and Lanzavecchia, A., Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. exp. Med., 182, 389400 (1995).
  • Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor α. J. exp. Med., 179, 11091118 (1994).
  • Sozzani, S., Sallusto, F., Luini, W., Zhou, D., Piemonti, L., Allavena, P., Van Damme, J., Valitutti, S., Lanzavecchia, A. and Mantovani, A., Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol., 155, 32923295 (1995).
  • Steinman, R., Hoffman, L. and Pope, M., Maturation and migration of cutaneous dendritic cells. J. invest. Dermatol., 105, 2S7S (1995).
  • Steinman, R. M., The dendritic cell system and its role in immunogenicity. Ann. Rev. Immunol., 9, 271297 (1991).
  • Thurnher, M., Radmayr, C., Hobisch, A., Böck, G., Romani, N., Bartsch, G. and Klocker, H., T lymphocytes from renal cell carcinoma express B7-1 (CD80): T cell expansion by T-T cell costimulation. Int. J. Cancer, 62, 559564 (1995).
  • Whiteside, T. L. and Parmiani, G., Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use. Cancer Immunol. Immunother., 39, 1521 (1994).
  • Young, J. W. and Inaba, K., Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. exp. Med., 183, 711 (1996).
  • Zhou, L.-J. and Tedder, T. F., Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol., 154, 38213835 (1995a).
  • Zhou, L.-J. and Tedder, T. F., A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells. Blood, 86, 32953301 (1995b).